SGLT2 Inhibition and Stimulation of Endogenous Glucose Production: Protocol 2

NCT02592421 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Type II Diabetes Mellitus

Interventions

DRUG: Dapagliflozin
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]